To define the threshold ethanol concentration that is toxic to cultured cells.
Methods:
Three malignant cell lines and freshly isolated normal rat hepatocytes were exposed to 0–50% (vol.) ethanol (concentrations used were 0, 5, 10, 15, 20, 25, 30, 40 and 50%) on tissue culture plates for 0.25–60 min (exposure times used were 0.25, 5, 10, 20, 30, 40, 50 and 60 min). Cytotoxicity was estimated by trypan blue exclusion test and from 3H-thymidine incorporation.
Results:
All cells were killed by a 15-s exposure to 30–40% ethanol while a concentration as low as 15–20% gave a total response after 5–10-min exposures. After a one-hour exposure of F9 carcinoma cells and hepatocytes, a total or nearly total response was achieved with 10% ethanol. The cytotoxic effect was thus dependent both on the exposure time and on the concentration of ethanol. There were no significant differences in ethanol tolerance among the cell types.
Conclusion:
Ethanol seemed to kill cells in the cell culture effectively in much lower concentrations than those currently used in tumour ablation.
BerryM. N.FriendD. S.: High-yield preparation of isolated rat liver parenchymal cells. J. Cell Biol.43 (1969), 506.
2.
Castrén-PersonsM.SchröderT.RämöO. J.PuolakkainenP.LehtonenE.: Contact Nd:YAG laser potentiates the tumor killing effect of hyperthermia. Lasers Surg. Med.11 (1991), 595.
3.
GiorgioA.TarantinoL.FrancicaG.ScalaV.MarinielloN.AloisioT.: Percutaneous ethanol injection under sonographic guidance of hepatocellular carcinoma in compensated and decompensated cirrhotic patients. J. Ultrasound Med.11 (1992), 587.
4.
IsobeH.FukaiT.IwamotoH.: Liver abscess complicating intratumoral ethanol injection therapy for HCC. Am. J. Gastroenterol.85 (1990), 1646.
5.
KodaM.OkamotoK.MiyoshiY.KawasakiH.: Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma. Gastrointest. Radiol.17 (1992), 167.
6.
KomiyamaK.TakekumaY.NekohashiT.AbeT.SatoiJ.: Fluoroscopic contrast medium percutaneous ethanol injection therapy (FCM-PEIT). Newly developed clinically useful method for injecting ethanol into nodules of hepatocellular carcinoma. (Abstract.)Nippon Shokakibyo Gakkai Zasshi91 (1994), 162.
7.
KotohK.SakaiH.SakamotoS.: The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am. J. Gastroenterol.89 (1994), 194.
8.
KurkiP.LaasonenA.TanE. M.LehtonenE.: Cell proliferation and expression of cytokeratin filaments in F9 embryonal carcinoma cells. Development106 (1989), 635.
9.
LehtonenE.LaasonenA.TienariJ.: Teratocarcinoma stem cells as a model for differentiation in the mouse embryo. Int. J. Dev. Biol.33 (1989), 105.
10.
LehtonenE.LehtoV. P.VartioT.BadleyR. A.VirtanenI.: Expression of cytokeratin polypeptides in mouse oocytes and preimplantation embryos. Dev. Biol.100 (1983), 158.
11.
LindrosK. O.PenttiläK. E.: Digitonin-collagenase perfusion for efficient separation of periportal or perivenous hepatocytes. Biochem. J.228 (1985), 757.
12.
LivraghiT.FestiD.MontiF.SalmiA.VettoriC.: US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology161 (1986), 309.
13.
LivraghiT.SalmiA.BolondiL.: Small hepatocellular carcinoma. Percutaneous alcohol injection — results in 23 patients. Radiology168 (1988), 313.
14.
LivraghiT.VettoriC.LazzaroniS.: Liver metastasis. Results of percutaneous ethanol injection in 14 patients. Radiology179 (1991), 709.
SalimA. S.: Chemonecrosis for localized dynamic destruction of hepatic metastases of colonic cancer. Oncology50 (1993), 18.
17.
SheuJ. C.SungJ. L.HuangG. T.: Intratumoral injection of absolute ethanol under ultrasound guidance for the treatment of small hepatocellular carcinoma. Hepatogastroenterology34 (1987), 255.
18.
ShiinaS.TagawaK.NiwaY.: Percutaneous ethanol injection therapy for hepatocellular carcinoma. Results in 146 patients. Am. J. Roentgenol.160 (1993), 1023.
19.
ShiinaS.TagawaK.UnumaT.: Percutaneous ethanol injection therapy for neoplasms located on the surface of the liver. Am. J. Roentgenol.155 (1990), 507.
20.
ShiinaS.TagawaK.UnumaT.TeranoA.: Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. Am. J. Roentgenol.154 (1990), 947.
21.
ShiinaS.YasudaH.MutoH.: Percutaneous ethanol injection in the treatment of liver neoplasms. Am. J. Roentgenol.149 (1987), 949.
22.
SolinasA.ErbellaG.DistruttiE.: Abscess formation in hepatocellular carcinoma. Complications of percutaneous ultrasound-guided ethanol injection. J. Clin. Ultrasound21 (1993), 531.
23.
TaavitsainenM.VehmasT.KauppilaR.: Fatal liver necrosis following percutaneous ethanol injection for hepatocellular carcinoma. Abdom. Imaging18 (1993), 357.
24.
TanakaK.OkazakiH.NakamuraS.: Hepatocellular carcinoma. Treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection. Radiology179 (1991), 713.
25.
TapaniE.VehmasT.TaavitsainenM.: Ultrasound monitoring of experimental ethanol injection into pig liver. Acad. Radiol.1 (1994), 21.
26.
TienariJ.LehtonenE.VartioT.VirtanenI.: Embryonal carcinoma cells adhere preferentially to fibronectin and laminin but their endodermal differentiation leads to reduced adherence to laminin. Exp. Cell Res.182 (1989), 26.
27.
TienariJ.PertovaaraL.SakselaO.LehtonenE.VartioT.: Increased expression of the matrix metalloproteinase 2 in differentiating Tera 2 human embryonal carcinoma cells. Int. J. Cancer56 (1994), 219.
28.
TienariJ.VirtanenI.SoinilaS.LehtonenE.: Neuronlike derivates of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells. Dev. Biol.123 (1987), 566.
